{
    "type": "ETP",
    "ucits": true,
    "replication_method": "synthetic",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "complex_factors": [
        "3x leveraged inverse exposure",
        "Use of derivatives and swaps for leverage and short exposure",
        "Collateralised debt security structure",
        "Daily reset leverage with compounding effects",
        "High risk rating (7/7)",
        "Potential counterparty risk due to collateralisation",
        "Complex benchmark with futures rolling and contango effects"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree Magnificent 7 3x Daily Short is a UCITS eligible Exchange Traded Product (ETP) that provides -3 times daily leveraged short exposure to the WisdomTree US Bluechip Select (GTR) Index. The product is a fully collateralised, English law governed, certificated, registered, collateralised debt security, indicating synthetic replication through derivatives and collateral arrangements. The KIID explicitly states the use of leverage (3x inverse exposure) and daily reset of leverage, which introduces compounding effects and deviation from the underlying index over periods longer than one day. The product uses derivatives and swaps to achieve its investment objective, as evidenced by references to costs and revenues inherent to shorting stocks, and the collateralised structure. The risk indicator is at the highest level (7/7), reflecting the high complexity and risk profile. The product is intended for informed investors with specific knowledge and experience, highlighting its complexity. The presence of futures contracts in the benchmark and the mention of rolling futures contracts imply additional complexity due to contango and backwardation effects. The product does not provide capital protection and carries counterparty risk due to its collateralised debt security nature. Transaction costs are significant (3.25% estimated annually), reflecting active management and derivative usage. All these factors combined classify the product as complex under MiFID II rules."
}